May 4 (Reuters) - Boule Diagnostics AB BOUL.ST :
* Q1 NET SALES SEK 132.5 MILLION VERSUS SEK 100.6 MILLION
YEAR AGO
* Q1 NUMBER OF INSTRUMENTS SOLD 1 207 VERSUS 931 YEAR AGO
* Q1 OPERATING PROFIT SEK 10.3 MILLION VERSUS SEK 6.8
MILLION YEAR
AGO
* ALTHOUGH SOME MARKETS, PARTICULARLY IN SOUTHEAST ASIA,
CONTINUE
TO BE AFFECTED BY THE PANDEMIC, SALES IN ASIA DOUBLED COMPARED
PREVIOUS YEAR
* SUPPLY OF ELECTRONIC COMPONENTS AND OTHER INPUTS CONTINUES
TO BE
VERY DIFFICULT AND DISRUPTIONS HAVE LIMITED PRODUCTION AND SALES
* Q1 GROSS PROFIT SEK 57 MILLION, CORRESPONDING TO A GROSS
MARGIN
OF 43 PERCENT, 1.5 PERCENTAGE POINT LOWER THAN LAST YEAR
* QUARTER WAS BURDENED BY COSTLY INPUTS BY APPROXIMATELY SEK
5
MILLION, UNEVEN PRODUCTION UTILIZATION AND HIGHER TRANSPORT
COSTS
* ALSO, GROSS MARGIN WAS AFFECTED BY UNFAVOURABLE
PRODUCT/REGION
MIX WITH HIGHER SHARE OF INSTRUMENTS TO INDIA IN PARTICULAR AND
AN INCREASED SHARE OF OEM SALES
Source text for Eikon: ID:nWkr7SFXNW
Further company coverage: BOUL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))